prices for glp-1 drugs Lilly's Zepbound price cut could reshape obesity drug market Novo cuts GLP-1 prices 70%,
Description
Knop FK, Bronden A, Vilsboll T
Proper storage extends medication shelf life and prevents waste
Paul Murray, Swiss Re's CEO of Life & Health Reinsurance, commented on these findings in a press release, noting that GLP-1 drugs hold "significant promise to help us beat the obesity epidemic." CLICK HERE TO GET THE FOX NEWS APP "Our research underscores that the full benefit will come from going beyond medication," he wrote
with liraglutide 3.51%, dulaglutide 2.33%, and tirzepatide showed a 2.31% change at the 12month mark
CRP often drops within 12 to 16 weeks
